Respiratory Syncytial Virus Infections
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant [Phase 2]
A Phase 2 clinical trial evaluating the persistence of immune response and safety after revaccination with an adjuvanted RSV vaccine in adul…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children [Phase 3]
A Phase 3 trial is evaluating azithromycin for respiratory failure caused by respiratory syncytial virus in children. The study is currently…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset
Pfizer is evaluating the benefits of maternal RSV vaccination using Scotland's national health dataset, and the study is currently not recru…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers
A prospective surveillance study on Respiratory Syncytial Virus infections in infants and toddlers has completed, sponsored by Sanofi Pasteu…